DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Hehlmann R, Lauseker M, Saußele S. et al.
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia 2017;
31 (11) 2398-2406

Download Bibliographical Data

Access:
Access:
Access: